Market intelligence
COAGSector not reported
Hemab Therapeutics Holdings, Inc. insider activity
In the last 90 days, 6 corporate insiders purchased $326,286,844 of stock on the open market.
SEC-reported filing activity is provided for research purposes and is not investment advice.
- 90-day C-suite buyers
- 0
- 90-day purchase value
- $326,286,844
- Corporate buyers
- 6
- Latest transaction
- Jun 16, 2026
Executive filings
Open-market transaction history
Purchase and sale summaries are ordered by the latest reported transaction date.
